Tag archive for ‘Repligen acquires Spectrum’
Repligen: Market Likes Spectrum Acquisition and So Do I (RGEN, Buy, $43.20)
Investment Thesis I view the acquisition of Spectrum, Inc. as a significant positive for Repligen as I will discuss shortly. I have recommended Repligen consistently since my initiation report of December 4, 2012 at a price of $6.13. My belief at the time and continues to be that this is one of the best healthcare […]